Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Iodine (¹³¹I) tositumomab

EU orphan designation number: EU/3/03/136
Active ingredient: Iodine (¹³¹I) tositumomab
Indication: Treatment of follicular lymphoma
Sponsor: GlaxoSmithKline Research & Development Limited
1-3 Iron Bridge Road, Stockley Park West, Uxbridge, Middlesex UB11 1BT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/02/2003 Orphan designation EMEA/OD/061/02 (2003)591 of 14/02/2003
19/08/2005 Transfer of orphan designation EMEA/OD/061/02/T/01 (2005)3237 of 17/08/2005
30/05/2011 Change of name and/or address of sponsor EMEA/OD/061/02
18/03/2015 Removal of orphan designation from Community Register